Mitochondrial Hypomagnesemia via the SARS2 Gene
Summary and Pricing 
Test Method
Exome Sequencing with CNV Detection
| Test Code | Test Copy Genes | Test CPT Code | Gene CPT Codes Copy CPT Code | Base Price | |
|---|---|---|---|---|---|
| 4977 | SARS2 | 81479 | 81479,81479 | $990 | Order Options and Pricing |
An additional 25% charge will be applied to STAT orders. STAT orders are prioritized throughout the testing process.
Click here for costs to reflex to whole PGxome (if original test is on PGxome Sequencing platform).
Click here for costs to reflex to whole PGnome (if original test is on PGnome Sequencing platform).
Turnaround Time
3 weeks on average for standard orders or 2 weeks on average for STAT orders.
Please note: Once the testing process begins, an Estimated Report Date (ERD) range will be displayed in the portal. This is the most accurate prediction of when your report will be complete and may differ from the average TAT published on our website. About 85% of our tests will be reported within or before the ERD range. We will notify you of significant delays or holds which will impact the ERD. Learn more about turnaround times here.
Targeted Testing
For ordering sequencing of targeted known variants, go to our Targeted Variants page.
Clinical Features and Genetics
Clinical Features
Primary hypomagnesemia is a heterogeneous group of disorders characterized by renal or intestinal Mg(2+) wasting, often associated with disturbances in Ca(2+) excretion (Viering et al. 2016). This electrolyte imbalance results in muscle cramps, muscle weakness and cardiac arrhythmias. Recessive pathogenic variants in the SARS2 gene have been reported to cause hypomagnesemia due to impaired mitochondrial function, which is characterized by hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis (also known as HUPRA syndrome) (Belostotsky et al. 2011; Viering et al. 2013).
Genetics
SARS2-associated hypomagnesemia is an autosomal recessive disorder (Belostotsky et al. 2011; Rivera et al. 2013). The SARS2 gene (16 coding exons) encodes mitochondrial seryl-tRNA synthetase, which provides serine aminoacylation to mitochondrial tRNAs. To date, only three missense variants in SARS2 have been reported to cause hypomagnesemia (Human Gene Mutation Database).
Clinical Sensitivity - Sequencing with CNV PGxome
Detection rate of pathogenic variants in the SARS2 gene in a large cohort of patients with HUPRA syndrome is unknown in the literature because only three missense pathogenic variants in SARS2 have been reported in limited cases (Human Gene Mutation Database).
Testing Strategy
This test provides full coverage of all coding exons of the SARS2 gene plus 10 bases of flanking noncoding DNA in all available transcripts along with other non-coding regions in which pathogenic variants have been identified at PreventionGenetics or reported elsewhere. We define full coverage as >20X NGS reads or Sanger sequencing. PGnome panels typically provide slightly increased coverage over the PGxome equivalent. PGnome sequencing panels have the added benefit of additional analysis and reporting of deep intronic regions (where applicable).
Dependent on the sequencing backbone selected for this testing, discounted reflex testing to any other similar backbone-based test is available (i.e., PGxome panel to whole PGxome; PGnome panel to whole PGnome).
Indications for Test
Candidates for this test are patients with HUPRA syndrome. Testing is also indicated for family members of patients who have known pathogenic variants in the SARS2 gene. This test may also be considered for the reproductive partners of individuals who carry pathogenic variants in SARS2.
Candidates for this test are patients with HUPRA syndrome. Testing is also indicated for family members of patients who have known pathogenic variants in the SARS2 gene. This test may also be considered for the reproductive partners of individuals who carry pathogenic variants in SARS2.
Gene
| Official Gene Symbol | OMIM ID |
|---|---|
| SARS2 | 612804 |
| Inheritance | Abbreviation |
|---|---|
| Autosomal Dominant | AD |
| Autosomal Recessive | AR |
| X-Linked | XL |
| Mitochondrial | MT |
Disease
| Name | Inheritance | OMIM ID |
|---|---|---|
| Hyperuricemia, Pulmonary Hypertension, Renal Failure, And Alkalosis | AR | 613845 |
Related Test
| Name |
|---|
| Hypomagnesemia Panel |
Citations
Ordering/Specimens
Ordering Options
We offer several options when ordering sequencing tests. For more information on these options, see our Ordering Instructions page. To view available options, click on the Order Options button within the test description.
myPrevent - Online Ordering
- The test can be added to your online orders in the Summary and Pricing section.
- Once the test has been added log in to myPrevent to fill out an online requisition form.
- PGnome sequencing panels can be ordered via the myPrevent portal only at this time.
Requisition Form
- A completed requisition form must accompany all specimens.
- Billing information along with specimen and shipping instructions are within the requisition form.
- All testing must be ordered by a qualified healthcare provider.
For Requisition Forms, visit our Forms page
If ordering a Duo or Trio test, the proband and all comparator samples are required to initiate testing. If we do not receive all required samples for the test ordered within 21 days, we will convert the order to the most effective testing strategy with the samples available. Prior authorization and/or billing in place may be impacted by a change in test code.
Specimen Types
Specimen Requirements and Shipping Details
PGxome (Exome) Sequencing Panel
PGnome (Genome) Sequencing Panel
Loading...
×
ORDER OPTIONS
View Ordering Instructions1) Select Test Type
2) Select Additional Test Options
No Additional Test Options are available for this test.